Loomis, Sayles & Company’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $21.5M | Sell |
|
|||||
|
2022
Q2 | $16.7M | Sell |
|
|||||
|
2022
Q1 | $28M | Buy |
|
|||||
|
2021
Q4 | $40.6M | Sell |
|
|||||
|
2021
Q3 | $40M | Sell |
|
|||||
|
2021
Q2 | $34.8M | Sell |
|
|||||
|
2021
Q1 | $39.2M | Buy |
|
|||||
|
2020
Q4 | $39.9M | Sell |
|
|||||
|
2020
Q3 | $33.1M | Buy |
|
|||||
|
2020
Q2 | $24.1M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $34.2M | Sell |
|
|||||
|
2019
Q3 | $32.3M | Buy |
|
|||||
|
2019
Q2 | $35.4M | Buy |
|
|||||
|
2019
Q1 | $29.7M | Buy |
|
|||||
|
2018
Q4 | $19.3M | Buy |
|
|||||
|
2018
Q3 | $6.58M | Buy |
|